CBU
PTCT icon

CIBC Bank USA’s PTC Therapeutics PTCT Stock Holding History

CIBC Bank USA’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$240K – 264
2018
Q4 		$240K Sell
7,000
-8,274
-54% -$298K 0.04% 210
2018
Q3 		$718K Sell
15,274
-1,000
-6% -$41.4K 0.1% 116
2018
Q2 		$549K Buy
+16,274
New +$508K 0.08% 140

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Bank USA's PTCT Position: Q1 2019 in Review

CIBC Bank USA sold out of PTC Therapeutics (PTCT) in Q1 2019, closing a stake of 7,000 shares — an estimated $240K sold.

CIBC Bank USA first reported a position in PTCT in Q2 2018 and held it in 3 quarters. The position peaked at $718K in Q3 2018. 174 funds tracked by Wall St. Rank hold PTCT as of Q1 2019.

  • CIBC Bank USA reported no remaining PTC Therapeutics position as of Q1 2019 after selling out during the quarter.
  • CIBC Bank USA sold 7,000 PTC Therapeutics shares in Q1 2019, an estimated $240K.
  • CIBC Bank USA first reported a position in PTC Therapeutics in Q2 2018 and held it in 3 quarters.
  • CIBC Bank USA's PTC Therapeutics position peaked at $718K in Q3 2018.
  • 174 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2019.

Based on CIBC Bank USA's 13F filing for Q1 2019, filed 10 May 2019.